Statements in which the resource exists as a subject.
PredicateObject
rdf:type
skos:definition
"A quinoline compound having a cyano group at the 3-position, a 3-chloro-4-(2-pyridylmethoxy)anilino group at the 4-position, a 4-dimethylamino-trans-but-2-enamido group at the 6-position, and an ethoxy group at the 7-position." []
skos:inScheme
skos:prefLabel
neratinib
skos:altLabel
(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
skos:notation
ChemIDplus:698387-09-6 "CAS Registry Number", CiteXplore:15715478 "PubMed citation", KEGG DRUG:D08950 "KEGG DRUG", Reaxys:9971763 "Reaxys Registry Number"
skos:broader
skos:relatedSynonym
neratinib, HKI 272, N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide, HKI-272, C30H31ClN6O2, CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC\\C=C\\CN(C)C, InChI=1S/C30H31ClN6O2/c1-4-38-29-17-26-24(16-27(29)34-13-7-8-14-37(2)3)30(21(18-32)19-35-26)36-22-10-11-28(25(31)15-22)39-20-23-9-5-6-12-33-23/h5-12,15-17,19,34H,4,13-14,20H2,1-3H3,(H,35,36)/b8-7+, InChIKey=ZNHPZUKZSNBOSQ-BQYQJAHWSA-N